LAUSANNE, Switzerland SOPHiA GENETICS, the global leader in Data-Driven Medicine that has created SOPHiA Artificial Intelligence, today announced the close of a $30 million Series D funding round. The round was led by London-based Balderton Capital joined by 360º Capital Partners alongside existing investors British tech star Mike Lynch’s Invoke Capital and Alychlo, the investment firm of Belgian pharmaceutical entrepreneur Marc Coucke. […]
MEDFORD, Mass. — GreenLight Biosciences, Inc. announced today the completion of its $18 million Series D round of financing led by Fall Line Capital. S2G Ventures, Lewis and Clark Ventures, and Macro Capital Investments participated in the round, along with the majority of GreenLight’s existing investors, including Kodiak Venture Partners, MLSCF, Syngenta Ventures and others. GreenLight is harnessing its […]
Grant funds the commercialization of a specialized Sydor Spectro CCD detector, designed for Soft X-ray Spectrometers Rochester, NY Sydor Instruments, a Sydor Technologies Company, announced today that it has been awarded a $991,741 SBIR Phase IIA grant from the Department of Energy, Office of Science to commercialize the unique Sydor Spectro CCD. Sydor Instruments will […]
PARIS—-Synthetic DNA manufacturer DNA Script has today announced a Series A fundraising of 11 million euros ($13 million) led by Illumina Ventures with additional investments from M Ventures, the corporate venture arm of Merck KGaA, Darmstadt, Germany, plus existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners. DNA Script is an industry leader in the […]
Seattle, WA – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the funding to advance its commercial sales efforts and build companion diagnostics (CDx) programs with strategic partners. The Company will also expand its regulatory infrastructure and research and development efforts. The $30M investment was led by 5AM Ventures with participation from […]
Notable private equity firm invests £2.5 million in the Cambridge-based biotech Private equity firm Calculus Capital, a leading EIS and VCT investor, has further expanded its life science portfolio, by investing £2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells produced from reprogrammed human blood and tissue cells. Axol supplies the world’s top […]
The agreement is to explore a next generation gene and cell therapy manufacturing platform for clinical and commercial applications London, UK: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group, has announced it has agreed, as lead partner, to enter into a collaboration agreement with a consortium of partners, […]
(Chelmsford, MA) Spectro Scientific, one of the world’s largest suppliers of oil, fuel, and processed-water analysis instrumentation and software, has won a $9.6 million contract from the U.S. Navy to provide fluid analysis equipment and support. In another recognition, the Office of Naval Research named Spectro personnel as finalists for proposing a portable fluid analysis […]
Offer Now Scheduled to Expire at 5:00 p.m., New York City Time, on August 28, 2017 WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that its wholly owned subsidiary, Thermo Fisher (CN) Luxembourg S.à r.l., has extended the offering period of its previously announced all-cash tender offer to […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) announced today that its tax benefit preservation plan had expired pursuant to its terms, effectively terminating the plan as of August 1, 2017. Stockholders are not required to take any action as a result of this expiration. In connection with the expiration of the tax benefit preservation plan, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
